These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. Carlson CM; Turpin EA; Moser LA; O'Brien KB; Cline TD; Jones JC; Tumpey TM; Katz JM; Kelley LA; Gauldie J; Schultz-Cherry S PLoS Pathog; 2010 Oct; 6(10):e1001136. PubMed ID: 20949074 [TBL] [Abstract][Full Text] [Related]
3. Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors. Li N; Ren A; Wang X; Fan X; Zhao Y; Gao GF; Cleary P; Wang B Proc Natl Acad Sci U S A; 2015 Jan; 112(1):238-43. PubMed ID: 25535343 [TBL] [Abstract][Full Text] [Related]
4. Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus. Oh S; McCaffery JM; Eichelberger MC J Virol; 2000 Jun; 74(12):5460-9. PubMed ID: 10823850 [TBL] [Abstract][Full Text] [Related]
5. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza. Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654 [TBL] [Abstract][Full Text] [Related]
7. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412 [TBL] [Abstract][Full Text] [Related]
8. Influenza type B neuraminidase can replace the function of type A neuraminidase. Ghate AA; Air GM Virology; 1999 Nov; 264(2):265-77. PubMed ID: 10562491 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of sialidase activity as a therapeutic approach. Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196 [TBL] [Abstract][Full Text] [Related]
10. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Eichelberger MC; Hassantoufighi A; Wu M; Li M Virol J; 2008 Sep; 5():109. PubMed ID: 18822145 [TBL] [Abstract][Full Text] [Related]
11. Activation of human platelet-derived latent transforming growth factor-beta 1 by human glioblastoma cells. Comparison with proteolytic and glycosidic enzymes. Huber D; Fontana A; Bodmer S Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):165-73. PubMed ID: 1830205 [TBL] [Abstract][Full Text] [Related]
12. The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis. Nichols JE; Niles JA; Fleming EH; Roberts NJ Virology; 2019 Aug; 534():80-86. PubMed ID: 31220651 [TBL] [Abstract][Full Text] [Related]
13. Correlation between levels of apoptosis, levels of infection and haemagglutinin receptor binding interaction of various subtypes of influenza virus: does the viral neuraminidase have a role in these associations. Mohsin MA; Morris SJ; Smith H; Sweet C Virus Res; 2002 May; 85(2):123-31. PubMed ID: 12034479 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor. Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843 [TBL] [Abstract][Full Text] [Related]
15. AML1 protein interacts with influenza A virus neuraminidase and upregulates IFN-β response in infected mammalian cells. Gaur P; Kumar P; Sharma A; Lal SK Lett Appl Microbiol; 2020 Apr; 70(4):252-258. PubMed ID: 31990997 [TBL] [Abstract][Full Text] [Related]